Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Donald Tusk says Nato is falling apart

      European leaders discussing strategic partnerships at a summit in Brussels, featuring key figures in formal attire

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Why Sunderland’s away kit legal row is a warning to all sports

      Breaking news event with diverse crowd gathered at a city park, showcasing community engagement and public discourse.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      What’s on in London in May

      City skyline view with modern skyscrapers under a clear blue sky in May, reflecting urban growth and economic vibrancy

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper
  • ISA Guide
  • Sign In
  • Sign Out
  • My Account

Legal

  • GSK: How much could the Zantac lawsuits cost?

    June 3, 2024

    Last month, Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares.

  • Mazars partners with Forvis to create £4bn global network as City hosts head office

    June 3, 2024

    Professional services firms Mazars and Forvis have come together to launched a £3.9bn ($4.7bn) global network

  • Last one standing: UK-US firm A&O Shearman latest to hike its junior lawyer salaries

    May 31, 2024

    One of the largest law firms in the world A&O Shearman has upped its newly-qualifie salary to £150,000 for its London lawyers

  • Court throws out case against Earl Spencer family bought by Oxford student’s mother over unpaid wages

    May 30, 2024

    A Tribunal has thrown out a University of Oxford student's case against the 8th Earl Spencer Family over his work at Estate Althorp House

  • Crispin Odey files defamation lawsuit against the Financial Times

    May 30, 2024

    Crispin Odey has launched legal proceedings against the FT according to court filings.

  • Legal regulator sets out ‘excessive’ fee hikes to boost drained industry fund

    May 29, 2024

    The legal regulator wants to increase law firm fees by 236 per cent in order to rebuild the sector's compensation fund after it was significantly impacted over the last year

  • Emma Sleep: CMA threatens legal action against mattress firm over pricing tactics

    May 29, 2024

    The Competition and Market Authority has threatened mattress company Emma Sleep with a lawsuit unless it "commits to changing its practices"

  • Next stop £195,000? Another law firm hikes junior lawyer pay

    May 29, 2024

    Clifford Chance is the latest magic circle firm to raise its newly-qualified salary in a salary war that has no sign of slowing down

  • Election leaves litigation funding Bill in limbo. What’s next for the multi-billion pound industry?

    May 29, 2024

    After a huge push from the funding industry to introduce a new law on litigation funding, the PM called on a snap election which now puts it into limbo

  • Tribunal reverses CMA’s £35m fine against four anti-nausea pharmaceutical firms

    May 28, 2024

    Four pharmaceutical companies have successfully appealed and reversed a £35m fine imposed by the competition regulator over anti-nausea tablets

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • …
  • Page 408
  • Next

Trending Articles

  • Jet fuel shortage looms as government scrambles to secure supplies

  • Labour will regret the Renters’ Rights Act

  • Mark Kleinman: Is it lights out for Ovo Energy?

  • Pension industry 1-0 Torsten Bell

  • Diageo launches the new Scotch whisky Rare Series aimed at private clients

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited